Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v1-EN
Language French English
Date Updated 2022-08-20 2022-07-19
Drug Identification Number 02297558 02297558
Brand name MEZAVANT MEZAVANT
Common or Proper name Mesalamine delayed- and extended-release tablets Mesalamine delayed- and extended-release tablets
Company Name TAKEDA CANADA INC TAKEDA CANADA INC
Ingredients MESALAZINE MESALAZINE
Strength(s) 1.2G 1.2G
Dosage form(s) TABLET (DELAYED AND EXTENDED RELEASE) TABLET (DELAYED AND EXTENDED RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 120 tablets / bottle 120 tablets / bottle
ATC code A07EC A07EC
ATC description INTESTINALANTIINFLAMMATORY AGENTS INTESTINALANTIINFLAMMATORY AGENTS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2022-07-18 2022-07-18
Actual start date 2022-07-18 2022-07-18
Estimated end date 2022-08-19 2022-08-05
Actual end date 2022-08-19
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments